New Cell Systems developed in collaboration with AIM Biotech

March 10th, 2025, Vienna, Austria

Two innovative 3D assay kits for advanced angiogenesis and vasculogenesis research have been developed in collaboration with our Singapore-based partner AIM Biotech.

Our human umbilical vein endothelial (HUVEC/TERT2) cells are pre-seeded in the AngioPrime kit to study angiogenesis in a controlled 3D environment, ideal for tumor research and anti-angiogenic therapy testing.

Our human umbilical vein endothelial (HUVEC/TERT2) and lung fibroblast (LF/TERT309) cell lines are pre-seeded into the VasQKit to create perfusable microvascular networks that mimic natural capillary formation.

This collaboration enables more precise, human-relevant drug screening by simulating complex organ interactions, and providing an advanced alternative to animal models.